 Nathan Donaldson
Concepts (119)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Osteomyelitis | 10 | 2025 | 146 | 2.390 |
Why?
| | Arthritis, Infectious | 5 | 2022 | 76 | 1.080 |
Why?
| | Knee | 1 | 2025 | 72 | 0.860 |
Why?
| | Laminectomy | 1 | 2021 | 31 | 0.680 |
Why?
| | Knee Joint | 1 | 2025 | 429 | 0.680 |
Why?
| | Kyphosis | 1 | 2021 | 37 | 0.660 |
Why?
| | Bone Neoplasms | 2 | 2025 | 265 | 0.650 |
Why?
| | Walking | 1 | 2025 | 545 | 0.640 |
Why?
| | Collagen Diseases | 1 | 2018 | 8 | 0.570 |
Why?
| | Hyaline Membrane Disease | 1 | 2018 | 20 | 0.570 |
Why?
| | Dwarfism | 1 | 2018 | 14 | 0.560 |
Why?
| | Osteochondrodysplasias | 1 | 2018 | 18 | 0.560 |
Why?
| | Sarcoma, Ewing | 3 | 2025 | 103 | 0.540 |
Why?
| | Spinal Fusion | 1 | 2021 | 262 | 0.540 |
Why?
| | Osteosarcoma | 1 | 2018 | 89 | 0.530 |
Why?
| | Cleft Palate | 1 | 2018 | 91 | 0.510 |
Why?
| | Face | 1 | 2018 | 175 | 0.500 |
Why?
| | Muscle, Skeletal | 1 | 2025 | 1791 | 0.430 |
Why?
| | Anti-Bacterial Agents | 4 | 2022 | 1925 | 0.390 |
Why?
| | Pyomyositis | 3 | 2022 | 15 | 0.380 |
Why?
| | Spine | 2 | 2024 | 182 | 0.330 |
Why?
| | Kingella kingae | 2 | 2022 | 12 | 0.320 |
Why?
| | Child | 14 | 2025 | 22740 | 0.220 |
Why?
| | Genetic Heterogeneity | 1 | 2025 | 66 | 0.220 |
Why?
| | Clonal Evolution | 1 | 2025 | 47 | 0.210 |
Why?
| | Spinal Diseases | 1 | 2024 | 50 | 0.200 |
Why?
| | Sarcoma | 2 | 2018 | 207 | 0.200 |
Why?
| | Child, Preschool | 7 | 2025 | 11868 | 0.200 |
Why?
| | Retrospective Studies | 10 | 2025 | 17330 | 0.190 |
Why?
| | Central Nervous System Diseases | 1 | 2024 | 74 | 0.190 |
Why?
| | Electromyography | 1 | 2025 | 419 | 0.190 |
Why?
| | Range of Motion, Articular | 1 | 2025 | 429 | 0.190 |
Why?
| | Neoplasms, Second Primary | 1 | 2024 | 102 | 0.190 |
Why?
| | Biomechanical Phenomena | 1 | 2025 | 860 | 0.170 |
Why?
| | Single-Cell Analysis | 1 | 2025 | 361 | 0.170 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2025 | 346 | 0.170 |
Why?
| | Central Nervous System Neoplasms | 1 | 2024 | 177 | 0.170 |
Why?
| | Musculoskeletal System | 1 | 2022 | 54 | 0.170 |
Why?
| | RNA, Neoplasm | 1 | 2021 | 83 | 0.170 |
Why?
| | Male | 13 | 2025 | 73010 | 0.160 |
Why?
| | Circulating Tumor DNA | 1 | 2021 | 46 | 0.160 |
Why?
| | Biomarkers, Tumor | 2 | 2025 | 1329 | 0.160 |
Why?
| | Humans | 18 | 2025 | 145783 | 0.150 |
Why?
| | Neisseriaceae Infections | 1 | 2018 | 6 | 0.140 |
Why?
| | Humerus | 1 | 2018 | 40 | 0.140 |
Why?
| | Female | 12 | 2025 | 79045 | 0.140 |
Why?
| | Incidental Findings | 1 | 2018 | 81 | 0.130 |
Why?
| | Bacterial Infections | 1 | 2020 | 247 | 0.130 |
Why?
| | Radiography, Thoracic | 1 | 2018 | 172 | 0.130 |
Why?
| | Drug Resistance, Bacterial | 1 | 2018 | 185 | 0.130 |
Why?
| | Drug Utilization Review | 1 | 2017 | 61 | 0.130 |
Why?
| | Adolescent | 7 | 2025 | 22577 | 0.130 |
Why?
| | Prevalence | 1 | 2024 | 2875 | 0.120 |
Why?
| | Brachytherapy | 1 | 2018 | 132 | 0.120 |
Why?
| | Soft Tissue Neoplasms | 1 | 2018 | 131 | 0.120 |
Why?
| | Radiation Dosage | 1 | 2018 | 193 | 0.120 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 91 | 0.120 |
Why?
| | Osteoarthritis | 1 | 2018 | 201 | 0.120 |
Why?
| | Young Adult | 2 | 2025 | 14254 | 0.110 |
Why?
| | Blood Sedimentation | 2 | 2025 | 37 | 0.110 |
Why?
| | Chronic Disease | 3 | 2025 | 1812 | 0.110 |
Why?
| | Treatment Outcome | 4 | 2025 | 11794 | 0.100 |
Why?
| | Rheumatology | 2 | 2025 | 133 | 0.100 |
Why?
| | Decision Support Techniques | 1 | 2018 | 480 | 0.100 |
Why?
| | Delphi Technique | 2 | 2025 | 333 | 0.100 |
Why?
| | Guideline Adherence | 1 | 2017 | 587 | 0.090 |
Why?
| | Practice Guidelines as Topic | 1 | 2017 | 1582 | 0.070 |
Why?
| | Risk Assessment | 2 | 2018 | 3752 | 0.070 |
Why?
| | Middle Aged | 2 | 2025 | 36309 | 0.050 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2025 | 81 | 0.050 |
Why?
| | Adult | 2 | 2025 | 40881 | 0.050 |
Why?
| | Length of Stay | 2 | 2020 | 1350 | 0.050 |
Why?
| | C-Reactive Protein | 1 | 2025 | 423 | 0.050 |
Why?
| | Sequence Analysis, RNA | 1 | 2025 | 442 | 0.050 |
Why?
| | Magnetic Resonance Imaging | 2 | 2025 | 3916 | 0.040 |
Why?
| | Prognosis | 2 | 2025 | 4330 | 0.040 |
Why?
| | Central Nervous System | 1 | 2024 | 282 | 0.040 |
Why?
| | Proto-Oncogene Protein c-fli-1 | 1 | 2021 | 30 | 0.040 |
Why?
| | RNA-Binding Protein EWS | 1 | 2021 | 31 | 0.040 |
Why?
| | Tumor Microenvironment | 1 | 2025 | 735 | 0.040 |
Why?
| | Translocation, Genetic | 1 | 2021 | 120 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 2000 | 0.040 |
Why?
| | Oncogene Proteins, Fusion | 1 | 2021 | 212 | 0.040 |
Why?
| | Clindamycin | 1 | 2018 | 14 | 0.040 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2025 | 1450 | 0.040 |
Why?
| | Methyltransferases | 1 | 2018 | 75 | 0.030 |
Why?
| | Surgical Wound Dehiscence | 1 | 2018 | 22 | 0.030 |
Why?
| | Gene Expression Profiling | 1 | 2025 | 1777 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2021 | 1043 | 0.030 |
Why?
| | Margins of Excision | 1 | 2018 | 50 | 0.030 |
Why?
| | Limb Salvage | 1 | 2018 | 73 | 0.030 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2018 | 222 | 0.030 |
Why?
| | Abscess | 1 | 2017 | 77 | 0.030 |
Why?
| | Neoplasm Grading | 1 | 2018 | 311 | 0.030 |
Why?
| | Central Venous Catheters | 1 | 2017 | 53 | 0.030 |
Why?
| | Incidence | 1 | 2024 | 2934 | 0.030 |
Why?
| | Medical Records | 1 | 2017 | 192 | 0.030 |
Why?
| | Drug Utilization | 1 | 2017 | 168 | 0.030 |
Why?
| | Fever | 1 | 2017 | 320 | 0.030 |
Why?
| | Wound Healing | 1 | 2018 | 355 | 0.030 |
Why?
| | Infant | 2 | 2022 | 10091 | 0.030 |
Why?
| | Surgical Wound Infection | 1 | 2018 | 329 | 0.030 |
Why?
| | Acute Disease | 1 | 2017 | 1036 | 0.030 |
Why?
| | Clinical Decision-Making | 1 | 2018 | 364 | 0.030 |
Why?
| | SEER Program | 1 | 2015 | 230 | 0.030 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 558 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2021 | 3418 | 0.020 |
Why?
| | Transcription Factors | 1 | 2021 | 1736 | 0.020 |
Why?
| | Quality of Health Care | 1 | 2017 | 693 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2015 | 1300 | 0.020 |
Why?
| | Predictive Value of Tests | 1 | 2018 | 2123 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2018 | 968 | 0.020 |
Why?
| | Patient Readmission | 1 | 2017 | 773 | 0.020 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2018 | 1150 | 0.020 |
Why?
| | Time Factors | 1 | 2018 | 7134 | 0.020 |
Why?
| | Risk Factors | 1 | 2018 | 10919 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2015 | 6465 | 0.010 |
Why?
| | Aged | 1 | 2018 | 26217 | 0.010 |
Why?
| | United States | 1 | 2015 | 16126 | 0.010 |
Why?
|
|
Donaldson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|